I believe modulating neurodegeneration is the fourth MOA of our little powerhouse that I can never state correctly. For newbies, Leronlimab has 4 MOAs, not just one. Let me see if I can state accurately and please help with your corrections.

1. CCR5 inhibitor
2. Halts Angiogenesis - blood supply to tumor
3. Repolarizes Macrophages
4. Modulates neurodegeneration - MS, Alzheimer’s, ALS and others

About correct?